Cat.#: ASSD-170
| Description | BAPTA-AM is a cell-permeable Ca2+ chelator that can be hydrolyzed by cytosolic esterases. The compound is used for the manipulation of cellular Ca2+ levels. BAPTA analog. |
| Size | 25 mg |
| Chemical Name | 1,2-Bis(2-aminophenoxy)ethane-N,N,N ',N'-tetraacetic acid tetrakis(acetoxymethyl ester) |
| Molecule Weight | 764.68 |
| Molecular formula | C34H40N2O18 |
| CAS Number | 126150-97-8 |
| PubChem identifier | 2293 |
| Purity | >95% |
| Solubility | Soluble in DMSO (30mM) |
| Storage | Store at -20° C |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ASSD-122 | Fluorescent β2 antagonist [(±)-propranolol] (AC122) | 500 μg | inquiry |
| ASSD-155 | Bromophenol blue (AC155) | 5g | inquiry |
| ASSD-199 | 4,7-Dioxaoctylenediamine N-[(Cyanine 3) Monofunctional Hexanoic Acid]-N′-[2-fluoro-4′-phosphophenylacetic Acid] Diamide (AC199) | 500 μg | inquiry |
| ASSD-125 | Fluorescent D1 antagonist [SKF83566-green] (AC125) | 50 μg | inquiry |
| ASSD-117 | Annexin V-PE Apoptosis Staining / Detection Kit (AC117) | 1 kit, 100 tests | inquiry |
| ASSD-131 | Calcein Blue (AC131) | 1 mg | inquiry |
| ASSD-207 | NBD-X acid (AC207) | 1 g | inquiry |
| ASSD-223 | Antifade Fluorescence Mounting Medium (aqueous) (AC223) | 10 mL | inquiry |
| ASSD-105 | Hoechst 33342 (AC105) | 10 mg, 100 mg | inquiry |
| ASSD-158 | Eosin Y (AC158) | 1g | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.